Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy.
about
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated EntitiesProgressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectProgressive multifocal leukoencephalopathy in HIV-1 infection.Natalizumab in Multiple Sclerosis: Long-Term Management.Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristicsHuman polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier.Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activityPre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.Natalizumab in the treatment of multiple sclerosisCompared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis.Differential distribution of the JC virus receptor-type sialic acid in normal human tissues.Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MSAssociation of DNA Methylation with Acute Mania and Inflammatory Markers.Progressive Multifocal Leukoencephalopathy after Three Consecutive Liver Transplantations.Management of infections by the human polyomavirus JC: past, present and future.JC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients.Natalizumab and progressive multifocal leucoencephalopathy.Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individualsAnalysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod.Human polyoma viruses and disease with emphasis on clinical BK and JC.Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating diseaseNatalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?Monoclonal antibody therapy in multiple sclerosis: Paradigm shifts and emerging challenges.Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.Human JC virus-like particles as a gene delivery vector.Natalizumab treatment of multiple sclerosis: new insights.Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.JCV serology in time: 3 years of follow-up.Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.Drug-Induced Progressive Multifocal Leukoencephalopathy: A Comprehensive Analysis of the WHO Adverse Drug Reaction Database.HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review.Association between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC).Prevalence of JC polyomavirus large T antigen sequences among Iranian patients with central nervous system tumors.Progressive multifocal leuconcephalopathy and autoimmune haemolytic anemia in chronic lymphocytic leukaemia: more than a fortuitous combination?Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products.Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.
P2860
Q26781389-707641C6-B6BE-4C22-91B0-747A479C4F7FQ33383576-EA53BDD3-BDB5-4CE1-8430-B6EF60435EB2Q33506561-70FB7845-FEE7-4044-9196-420616AE3BB0Q33754882-A903FD46-A0C0-43BA-9FF5-32D4B566215EQ34065462-9304E911-45AF-4FDD-8495-709256A73391Q34085827-09AC656C-C430-4170-9CEE-BE01D46ADF98Q34136900-DE9FE103-46F4-422E-B5FC-2574EEA90877Q34230150-F14D20E3-882E-46FF-BABE-175BB2F647F6Q34409340-32112FC9-73C8-4D96-A6F9-40749858D15DQ34630494-4C4950E5-5420-43ED-990D-CA95254A46ADQ35083490-42DC3708-66B1-4E95-AD9F-4F436D0ABEA4Q35476415-9158CB80-E939-4C7D-B9C4-2F6F079EF0B7Q35683741-4065D666-7BD9-4755-9D8E-DE106F2E20DEQ35983882-9D4C35D1-4417-4133-B54F-8BCF3BF6E237Q36233526-6B972F64-E38B-46A2-8205-F1259F7BBC9BQ36572168-5A25E661-5154-4217-A2B2-4CEAFF5C91D3Q36622383-FCF02CC6-85D6-42D7-8D5D-96C56B02F05CQ37002106-724719B6-1457-4559-BB4E-C62FFC642D94Q37196796-BD4C62DE-7952-417C-ACCE-D2B8B7D001A9Q37361949-CF70D08E-7141-4C68-BBB2-258247EA80E2Q37475542-98B16F53-C89B-41AA-B87B-C0F3DF16F3D2Q37671117-152DCA03-5AA2-4EB8-AEF0-B3D2408EFEF9Q37750534-FDAF62F6-9B5C-4EF9-BA56-1B6CCB54FD56Q37778944-72A94ED4-633B-485D-8F30-D7B76264B456Q37814815-C6785279-BCA4-4D42-9A00-CC52FF38E449Q37816551-C697CB40-A494-44BB-9625-B5D29383DD11Q37873489-BCB20881-0E5B-45BF-9BA7-ECB18692E588Q39048568-EC1DDFE1-BA8E-48AE-975C-CCF64BBFCFF9Q39211049-B365DCA9-F3D7-46C3-B551-530237F1049CQ39263983-954DD343-C308-40F4-BA0C-3FFE453960FFQ39391443-15A20640-E4C3-439F-B420-A7BBB09FDD03Q39487528-1B5E5DCD-4497-43F8-90CC-9C32F76ACCB8Q41178481-95DC129A-1110-409A-B54C-16F58AA22240Q41509979-E71381A8-90A2-4B6D-9A2C-6B631F616F27Q41924854-6DC087BA-C271-473A-B781-8DF52D856D2EQ42182618-AE6BB2E0-A865-4035-BF83-80FB75EFEA18Q42188652-45306F8A-03B9-4B08-8D0E-D8A31950C589Q43225253-F677307E-3533-4465-8B8A-4C556D466A22Q45410532-86D25EF4-D80E-498C-8A5A-C206CAE2608AQ47565422-80E7189B-7944-4F15-B0B7-98EBBF1A6C87
P2860
Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@ast
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@en
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@nl
type
label
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@ast
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@en
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@nl
prefLabel
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@ast
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@en
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@nl
P356
P1476
Traffic of JC virus from sites ...... ultifocal leukoencephalopathy.
@en
P2093
Bruce F Sabath
Eugene O Major
P304
P356
10.1086/344280
P407
P478
186 Suppl 2
P577
2002-12-01T00:00:00Z